Past, present and future uses of methacholine testing
暂无分享,去创建一个
[1] C. Jackson,et al. A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial. , 2012, Chest.
[2] C. Lemière,et al. Comparison of methacholine and mannitol bronchial provocation tests in workers with occupational asthma. , 2012, The Journal of allergy and clinical immunology.
[3] A. McIvor,et al. Update on exhaled nitric oxide in pulmonary disease , 2012, Expert review of respiratory medicine.
[4] K. Killian,et al. Dose–response effects of TPI ASM8 in asthmatics after allergen , 2011, Allergy.
[5] G. Ciprandi,et al. Relationship between bronchial hyperreactivity and bronchodilation in patients with allergic rhinitis. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[6] M. Dolhnikoff,et al. Cholinergic Hyperresponsiveness of Peripheral Lung Parenchyma in Chronic Obstructive Pulmonary Disease , 2011, Respiration.
[7] L. Boulet,et al. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. , 2011, American journal of respiratory and critical care medicine.
[8] D. Jarvis,et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. , 2011, American journal of respiratory and critical care medicine.
[9] M. Chan-yeung,et al. Airway hyperresponsiveness to methacholine in 7‐year‐old children: sensitivity and specificity for pediatric allergist‐diagnosed asthma , 2011, Pediatric Pulmonology.
[10] J. Fahy,et al. Negative methacholine challenge tests in subjects who report physician‐diagnosed asthma , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[11] C. Porsbjerg,et al. Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study. , 2010, The Journal of allergy and clinical immunology.
[12] C. Roussos,et al. Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice , 2010, International journal of chronic obstructive pulmonary disease.
[13] F. Hargreave,et al. Airway Hyperresponsiveness in Asthma: Its Measurement and Clinical SignificanceMeasuring Bronchitis in Airway Diseases: Clinical Implementation and Application: Airway Hyperresponsiveness in Asthma: Its Measurement and Clinical Significance , 2010 .
[14] J. Brannan. Bronchial hyperresponsiveness in the assessment of asthma control: Airway hyperresponsiveness in asthma: its measurement and clinical significance. , 2010, Chest.
[15] S. Anderson,et al. Indirect Challenge Tests Airway Hyperresponsiveness in Asthma : Its Measurement and Clinical Signifi cance , 2010 .
[16] L. Boulet,et al. Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma. , 2009, The Journal of allergy and clinical immunology.
[17] C. Porsbjerg,et al. Diagnostic properties of inhaled mannitol in the diagnosis of asthma: a population study. , 2009, The Journal of allergy and clinical immunology.
[18] L. Boulet,et al. Single-dose desloratadine and montelukast and allergen-induced late airway responses , 2009, European Respiratory Journal.
[19] L. Boulet,et al. Comparative airway response to high- versus low-molecular weight agents in occupational asthma , 2009, European Respiratory Journal.
[20] P. Calverley,et al. Lung function changes following methacholine inhalation in COPD. , 2009, Respiratory medicine.
[21] S. Anderson,et al. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma , 2009, Respiratory research.
[22] L. Williams,et al. Two ATS Recommended Protocols for Administration of Methacholine Are Not Equal , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.
[23] T. Ahmed,et al. The effect of IVX‐0142, a heparin‐derived hypersulfated disaccharide, on the allergic airway responses in asthma , 2008, Allergy.
[24] L. Boulet,et al. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. , 2008, American journal of respiratory and critical care medicine.
[25] A. Kozyrskyj,et al. Diagnosing asthma in children: What is the role for methacholine bronchoprovocation testing? , 2008, Pediatric pulmonology.
[26] S. Anderson,et al. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[27] S. Anderson,et al. Monitoring asthma therapy using indirect bronchial provocation tests * , 2007, The clinical respiratory journal.
[28] Y. Jiong,et al. Persistent airway inflammation and bronchial hyperresponsiveness in patients with totally controlled asthma , 2007, International journal of clinical practice.
[29] I. Pavord,et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. , 2007, American journal of respiratory and critical care medicine.
[30] D. Cockcroft,et al. Mechanisms of airway hyperresponsiveness. , 2006, The Journal of allergy and clinical immunology.
[31] L. Prieto,et al. Effect of challenge method on sensitivity, reactivity, and maximal response to methacholine. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[32] D. Cockcroft,et al. The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result. , 2006, The Journal of allergy and clinical immunology.
[33] D. Cockcroft,et al. Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection. , 2005, Chest.
[34] J. Cowan,et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.
[35] S. Anderson,et al. Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. , 2005, Pulmonary pharmacology & therapeutics.
[36] D. Cockcroft,et al. Methacholine challenge: comparison of two methods. , 2005, Chest.
[37] D. Cockcroft,et al. Dosimeter methacholine challenge: comparison of maximal versus submaximal inhalations. , 2004, The Journal of allergy and clinical immunology.
[38] Jan Stolk,et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[39] D. Postma,et al. Direct or indirect stimuli for bronchial challenge testing: what is the relevance for asthma epidemiology? , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[40] S. Anderson,et al. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. , 2003, Chest.
[41] L. Corbetta,et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[42] S. Holgate,et al. Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation. , 2002, The Journal of allergy and clinical immunology.
[43] P. O'Byrne,et al. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. , 2002, American journal of respiratory and critical care medicine.
[44] C. Jenkins,et al. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. , 2001, European Respiratory Journal.
[45] D. Cockcroft,et al. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo. , 1999, The Journal of allergy and clinical immunology.
[46] J. Vandenbroucke,et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.
[47] Boulet,et al. Directives de la Societe canadienne de thoracologie pour l'asthme professionnel canadian thoracic society guidelines for occupational asthma , 1998, Canadian respiratory journal.
[48] D. Yates,et al. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma. , 1998, Thorax.
[49] M. W. Jensen,et al. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. , 1997, American journal of respiratory and critical care medicine.
[50] D. Cockcroft,et al. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. , 1997, Thorax.
[51] A. Zwinderman,et al. Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma. , 1997, The Journal of allergy and clinical immunology.
[52] R. Pauwels,et al. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .
[53] S. Durham,et al. A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[54] D. Jarvis,et al. The European Community Respiratory Health Survey II , 1994, European Respiratory Journal.
[55] D. Cockcroft,et al. Regular inhaled salbutamol and airway responsiveness to allergen , 1993, The Lancet.
[56] P. Barnes,et al. Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in Asthma , 1992 .
[57] S. Holgate,et al. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. , 1989, The American review of respiratory disease.
[58] F. Speizer,et al. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. , 1987, The American review of respiratory disease.
[59] D. Cockcroft,et al. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. , 1987, The Journal of allergy and clinical immunology.
[60] M. Yamakido,et al. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma. , 2009, Allergology international : official journal of the Japanese Society of Allergology.
[61] S. Willsie. Allergic Rhinitis and Onset of Bronchial Hyperresponsiveness: A Population-based Study , 2009 .
[62] L. Boulet,et al. Adult Asthma Consensus Guidelines update 2003. , 2004, Canadian respiratory journal.
[63] J. Hankinson,et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.
[64] L. Boulet,et al. Canadian Thoracic Society guidelines for occupational asthma. , 1998, Canadian respiratory journal.
[65] J. Connett,et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.
[66] P. Barnes,et al. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. , 1992, The New England journal of medicine.
[67] A. Zwinderman,et al. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. , 1991, The American review of respiratory disease.